ORAMED PHARMACEUTICALS INC. cotiza a 4.27 USD y tiene una capitalización bursátil de $178M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has l…
| Periodo | 2026-11 | 2026-08 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | — | $1.84 | $0.25 | $1.13 |
| Estimado | $0.43 | $0.43 | — | $-0.04 |
| Sorpresa | — | +327.9% | — | +2925.0% |
| Métrica | ORMP | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 0.7% | 57.0% | -56.4% |
| Operating Margin | -754.4% | -38.6% | -715.8% |
| Net Margin | 3202.5% | -33.6% | +3236.1% |
| FCF Margin | -457.7% | -13.9% | -443.8% |
| ROE | 32.1% | -40.4% | +72.5% |
| ROA | 27.7% | -32.0% | +59.8% |
| Current Ratio | 6.98 | 2.84 | +4.14 |
| Debt / Equity | — | 0.28 | — |